MC3 Recorded Education Series: Attention Deficit Hyperactivity Disorder
To begin this activity, click Enroll. Once logged in, learners can access educational content, assessments, and evaluations. Learners who successfully complete the activity will be able to print a certificate.
criteria for attention deficit hyperactivity disorder, have an approach to the evaluation of youth with suspected attention deficit hyperactivity disorder, as well as understand the evidence-based nonpharmacologic and pharmacologic management strategies to treat attention deficit hyperactivity disorder in youth.
Accreditation and Credit Designation
The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Michigan Medical School designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Release Date: 04/02/19
Termination Date: 03/31/22
Nasuh Malas, MD, MPH
Anne Kramer, MSW
Erin Hughes Kramer, MSW
Nasuh Malas, MD, MPH
There are no relevant financial relationships with ACCME-defined commercial interests to disclose for this activity.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5thEdition. Arlington, VA. American Psychiatric Association 2013
Correll CU, Kratochvil CJ, March JS. "Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics." Journal of Clinical Psychiatry 2011. 72(5): 655-670
Polanczyk, G Epidemiology of ADHD across the lifespan. Curr Opinion Psych 20(386-92); 2007
Vitiello B, et al. (2007). Effectiveness of methylphenidatein the 10-month continuation phase of the preschoolers with ADHD treatmentstudy (PATS). Journal of Child and Adolescent Psychopharmacology, 17(5): 593-603.
Martin, A. Lewis's Child and Adolescent psychiatry, a comprehensive textbook, Fourth Ed. 2007.
The MTA cooperative Group. "A 14 month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder." Arch of Gen Psychiatry, 1999; 56;1073-1086.